Capital One National Association’s ANI Pharmaceuticals ANIP Stock Holding History

Capital One National Association’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$335K	Buy	+5,008	New	+$313K	0.02%	396

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Capital One National Association's ANIP Position: Q2 2018 in Review

Capital One National Association opened a new position in ANI Pharmaceuticals (ANIP) in Q2 2018: 5,008 shares worth $335K. The stake represents 0.02% of the portfolio and ranks #396 among its holdings.

184 funds tracked by Wall St. Rank hold ANIP as of Q2 2018.

Capital One National Association held 5,008 shares of ANI Pharmaceuticals worth $335K as of Q2 2018.
ANI Pharmaceuticals was a new Capital One National Association position in Q2 2018.
ANI Pharmaceuticals made up 0.02% of Capital One National Association's portfolio in Q2 2018, its #396 holding.
184 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2018.

Based on Capital One National Association's 13F filing for Q2 2018, filed 16 Jul 2018.